H G Skelton1, K J Smith, W B Laskin
1Department of Dermatopathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Desmoplastic malignant melanoma (DMM) shows a better prognosis than other melanomas, with a 5-year disease-free survival rate of 61%. Tumor depth and stromal mucin presence are key factors influencing survival in DMM patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: